A month's worth of weekly injections of semaglutide and tirzepatide in the United States in 2024 cost upwards of US $1,000 which puts it out of the reach of many (Blackman)
GLP-1 drugs commonly cause nausea, constipation, or an uncomfortable sense of fullness, especially early on, because they slow digestion
The company serves all 50 states without requiring insurance, membership fees, or prior authorization, and all products qualify for HSA and FSA savings accounts, creating multiple pathways to affordability
For these patients, the benefits are particularly valuable
Always consult a qualified healthcare professional before making changes to your health routine.